4.6 Review

Update on Cystatin C: Incorporation Into Clinical Practice

期刊

AMERICAN JOURNAL OF KIDNEY DISEASES
卷 62, 期 3, 页码 595-603

出版社

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.ajkd.2013.03.027

关键词

Cystatin C; glomerular filtration rate (GFR) estimation; chronic kidney disease

资金

  1. National Institute of Health (NIH)/National Institute on Aging [5R01AG034853-03, 5R01AG027002-06]
  2. NIH/National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK087961-01A1, K23 DK082793]

向作者/读者索取更多资源

Kidney function monitoring using creatinine-based glomerular filtration rate estimation is a routine part of clinical practice. Emerging evidence has shown that cystatin C may improve classification of glomerular filtration rate for defining chronic kidney disease in certain clinical populations and assist in understanding the complications of chronic kidney disease. In this review and update, we summarize the overall literature on cystatin C, critically evaluate recent high-impact studies, highlight the role of cystatin C in recent kidney disease guidelines, and suggest a practical approach for clinicians to incorporate cystatin C into practice. We conclude by addressing frequently asked questions related to implementing cystatin C use in a clinical setting. (C) 2013 by the National Kidney Foundation, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据